This study is testing the safety and effectiveness of a new two-drug combination for people with advanced colorectal and other gastrointestinal cancers that have stopped responding to standard treatments. The trial combines an oral pill (vorbipiprant) with an immunotherapy drug (…
Phase: PHASE1, PHASE2 • Sponsor: Rottapharm Biotech • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC